Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
48
MSADF Quote, Financials, Valuation and Earnings
Last price:
$21.61
Seasonality move
:
47.3%
Day range:
$19.99 - $21.61
52-week range:
$17.04 - $25.00
Dividend yield:
3.13%
P/E ratio:
7.27x
P/S ratio:
0.79x
P/B ratio:
1.22x
Volume:
467
Avg. volume:
23.1K
1-year change:
-7.08%
Market cap:
$32.7B
Revenue:
$41.7B
EPS (TTM):
$2.97
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $45.5B | $44.6B | $37.4B | $43.9B | $41.7B | |
| Revenue Growth (YoY) | 6.21% | -1.97% | -16.05% | 17.34% | -5.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.5B | $6.2B | $5.4B | $5.5B | $5.6B | |
| Other Inc / (Exp) | $3.3B | $872.9M | $282.8M | $2B | $379.4M | |
| Operating Expenses | $7.6B | $6.5B | $5.8B | $6.1B | $6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $137.7M | $137.9M | $76.9M | $72.4M | $77.4M | |
| EBT. Incl. Unusual Items | $1.9B | $3.3B | $2.2B | $3.2B | $6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $509.9M | $927.1M | $607.4M | $619.8M | $1.4B | |
| Net Income to Company | $1.9B | $3.3B | $2.2B | $3.2B | $6B | |
| Minority Interest in Earnings | -$30.9M | -$28.1M | -$26.5M | -$24.6M | -$32.8M | |
| Net Income to Common Excl Extra Items | $1.4B | $2.3B | $1.6B | $2.6B | $4.5B | |
| Basic EPS (Cont. Ops) | $0.80 | $1.41 | $0.32 | $1.61 | $2.92 | |
| Diluted EPS (Cont. Ops) | $0.80 | $1.41 | $0.32 | $1.61 | $2.92 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $4.8B | $1.6B | $1.6B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $4.8B | $1.6B | $1.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $3.4B | $2.3B | $3.3B | $6B | |
| Revenue (Reported) | $45.5B | $44.6B | $37.4B | $43.9B | $41.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $3.4B | $2.3B | $3.3B | $6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.9B | $38.5B | $16.8B | $17.6B | -$7.1B | |
| Revenue Growth (YoY) | -7.62% | 251.33% | -56.28% | 4.84% | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.5B | $1.3B | $1.3B | $1.3B | |
| Other Inc / (Exp) | $878.9M | $270.6M | $30M | $355M | $76.5M | |
| Operating Expenses | $1.8B | $1.5B | $1.2B | $1.3B | $1.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $34.4M | $34.6M | $18.1M | $18.3M | $19.9M | |
| EBT. Incl. Unusual Items | $883.1M | $980.5M | $1.3B | $1.7B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $363.9M | $271M | $333.5M | $411.4M | $398.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$7.7M | -$7.5M | -$4.2M | -$6.2M | -$5.2M | |
| Net Income to Common Excl Extra Items | $511.5M | $701.9M | $994.2M | $1.3B | $1.1B | |
| Basic EPS (Cont. Ops) | $0.30 | $0.42 | $0.61 | $0.82 | $0.72 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.42 | $0.61 | $0.82 | $0.72 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $917.5M | $1B | $1.4B | $1.8B | $1.5B | |
| Revenue (Reported) | $10.9B | $38.5B | $16.8B | $17.6B | -$7.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $917.5M | $1B | $1.4B | $1.8B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $45.5B | $45.2B | $36.1B | $44.6B | $42.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.5B | $6.2B | $5.4B | $5.5B | $5.6B | |
| Other Inc / (Exp) | $3.3B | $883.4M | $286M | $2B | $384.3M | |
| Operating Expenses | $7.6B | $6.5B | $5.8B | $6B | $6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $137.7M | $137.9M | $76.8M | $72.4M | $78.3M | |
| EBT. Incl. Unusual Items | $1.9B | $3.3B | $2.2B | $3.2B | $6.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $513.3M | $927.3M | $608.6M | $624.4M | $1.4B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$30.9M | -$28.2M | -$26.7M | -$24.5M | -$33.3M | |
| Net Income to Common Excl Extra Items | $1.4B | $2.3B | $1.6B | $2.6B | $4.6B | |
| Basic EPS (Cont. Ops) | $0.80 | $1.41 | $0.97 | $1.60 | $2.97 | |
| Diluted EPS (Cont. Ops) | $0.80 | $1.41 | $0.96 | $1.60 | $2.97 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $3.4B | $2.3B | $3.3B | $6.1B | |
| Revenue (Reported) | $45.5B | $45.2B | $36.1B | $44.6B | $42.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $3.4B | $2.3B | $3.3B | $6.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $61.2B | $51.2B | $60.6B | $3.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.6B | $3.9B | $4B | $2.7B | -- | |
| Other Inc / (Exp) | $876.3M | $123.9M | $1.1B | $334.8M | -- | |
| Operating Expenses | $4.6B | $3.8B | $4B | $2.7B | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $106M | $58.6M | $55.9M | $38.2M | -- | |
| EBT. Incl. Unusual Items | $2.6B | $1.5B | $2.6B | $3.2B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $719M | $419.2M | $640.7M | $817.6M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$24.5M | -$19.6M | -$18.4M | -$14M | -- | |
| Net Income to Common Excl Extra Items | $1.8B | $1B | $2B | $2.4B | -- | |
| Basic EPS (Cont. Ops) | $1.11 | $0.63 | $1.23 | $1.55 | -- | |
| Diluted EPS (Cont. Ops) | $1.10 | $0.62 | $1.23 | $1.55 | -- | |
| Weighted Average Basic Share | $5B | $4.9B | $4.8B | $3.1B | -- | |
| Weighted Average Diluted Share | $5B | $4.9B | $4.8B | $3.1B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.7B | $1.5B | $2.7B | $3.3B | -- | |
| Revenue (Reported) | $61.2B | $51.2B | $60.6B | $3.9B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.7B | $1.5B | $2.7B | $3.3B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Property Plant And Equipment | $4.5B | $4B | $3.6B | $3.1B | $3.1B | |
| Long-Term Investments | $152.2B | $138.9B | $121.2B | $120B | $118.7B | |
| Goodwill | $1.1B | $1B | $1.1B | $934.5M | $889.8M | |
| Other Intangibles | $2.8B | $2.6B | $2.6B | $2.3B | $2.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $218.9B | $205.1B | $182.7B | $178.1B | $175.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $7.3B | $6.4B | $5.4B | $4.7B | $3.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $190.5B | $178B | $159.2B | $148.3B | $148.3B | |
| Common Stock | $909M | $823.7M | $756.6M | $667.8M | $677.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $28B | $26.7B | $23.2B | $29.5B | $26.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $374.3M | $353.1M | $355.6M | $306.4M | $349M | |
| Total Equity | $28.3B | $27.1B | $23.6B | $29.8B | $27.1B | |
| Total Liabilities and Equity | $218.9B | $205.1B | $182.7B | $178.1B | $175.4B | |
| Cash and Short Terms | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Total Debt | $7.3B | $6.4B | $5.4B | $4.7B | $3.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Property Plant And Equipment | $4.5B | $4B | $3.6B | $3.1B | $3.1B | |
| Long-Term Investments | $152.2B | $138.9B | $121.2B | $120B | $118.7B | |
| Goodwill | $1.1B | $1B | $1.1B | $934.5M | $889.8M | |
| Other Intangibles | $2.8B | $2.6B | $2.6B | $2.3B | $2.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $218.9B | $205.1B | $182.7B | $178.1B | $175.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $7.3B | $6.4B | $5.4B | $4.7B | $3.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $190.5B | $178B | $159.2B | $148.3B | $148.3B | |
| Common Stock | $909M | $823.7M | $756.6M | $667.8M | $677.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $374.3M | $353.1M | $355.6M | $306.4M | $349M | |
| Total Equity | $28.3B | $27.1B | $23.6B | $29.8B | $27.1B | |
| Total Liabilities and Equity | $218.9B | $205.1B | $182.7B | $178.1B | $175.4B | |
| Cash and Short Terms | $18.7B | $19.3B | $20.8B | $19.2B | $14.3B | |
| Total Debt | $7.3B | $6.4B | $5.4B | $4.7B | $3.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $3.3B | $2.2B | $3.2B | $6B | |
| Depreciation & Amoritzation | $793M | $865M | $792.3M | $838.6M | $800.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.1B | $2.1B | $1.4B | $3.8B | $4.3B | |
| Capital Expenditures | $859.4M | $722.9M | $604.5M | $588.6M | $579.7M | |
| Cash Acquisitions | -- | -$90M | -$333.3M | -- | -- | |
| Cash From Investing | $414.4M | -$641.1M | $3.6B | -$1.9B | -$3.7B | |
| Dividends Paid (Ex Special Dividend) | -$801.1M | -$804M | -$790.6M | -$811.7M | -$1.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $936.9M | $1.3B | -- | -- | $8.2M | |
| Long-Term Debt Repaid | -$943.3M | -$1.6B | -$1.3B | -$693M | -$828.8M | |
| Repurchase of Common Stock | -$330.5M | -$363.8M | -$412.8M | -$210.5M | -$1.6B | |
| Other Financing Activities | $1.9B | $2B | $153M | $135.1M | -$583.4M | |
| Cash From Financing | $747.8M | $521.5M | -$2.3B | -$1.6B | -$4.3B | |
| Beginning Cash (CF) | $20.7B | $17.8B | $16.7B | $18.3B | $17.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.9B | $2B | $2.7B | $284.8M | -$3.7B | |
| Ending Cash (CF) | $18.8B | $20.1B | $19.6B | $18.9B | $14.7B | |
| Levered Free Cash Flow | -$3.9B | $1.4B | $833.3M | $3.2B | $3.8B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $458.8M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $444.5M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$1.1B | -- | |
| Capital Expenditures | -- | -- | $177.7M | $471.6M | $84.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $1.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$248.1M | -$454M | $13.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$230.2M | -- | |
| Other Financing Activities | -- | -- | -- | $20.4M | -- | |
| Cash From Financing | -- | -- | -- | -$642.7M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$7.5M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$1.6B | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get MSADF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MSADF
Sector
P/E ratio
7.27x
12.18x
PEG ratio
0.20x
0.40x
P/B ratio
1.22x
1.10x
Price / LTM sales
0.79x
2.66x
Growth Metrics
MSADF
Sector
Revenue growth
-15.02%
5.1%
Earnings growth
42.09%
2.61%
Revenue (5-year growth)
-0.55%
5.17%
Earnings forecast
--
$0.61
Profitability
MSADF
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
14.06%
5.2%
Return on assets
2.56%
0.97%
Return on equity
16.36%
9.24%
Earnings Date
Last Earnings Date
May
20
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
19
Balance Sheet
MSADF
Sector
Total cash
$14.3B
$452M
Short term investments
--
$220.9M
Total assets
$175.4B
$3.8B
Long term debt
$3.9B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
